Greve Sara V, Laurent Stephan, Olsen Michael H
Department of Endocrinology, Cardiovascular and Metabolic Preventive Clinic, Centre for Individualized Medicine in Arterial Diseases, Odense University Hospital, Odense, Denmark.
INSERM U 970, Team 7, Paris Cardiovascular Research Center (PARCC), Hôpital Européen Georges Pompidou, Paris, France.
Pulse (Basel). 2017 Jan;4(4):175-179. doi: 10.1159/000453073. Epub 2016 Dec 1.
In a recently published paper, Greve et al [J Hypertens 2016;34:1279-1289] investigate whether the estimated carotid-femoral pulse wave velocity (ePWV), calculated using an equation derived from the relationship between carotid-femoral pulse wave velocity (cfPWV), age, and blood pressure, predicts cardiovascular disease (CVD) as good as the measured cfPWV. Because ePWV predicts CVD as good as cfPWV, some might wonder whether ePWV could be replaced by cfPWV, which is a time-consuming measurement requiring an expensive apparatus. This question is addressed in this mini-review.
在最近发表的一篇论文中，格雷夫等人[《高血压杂志》2016年；34:1279 - 1289]研究了使用由颈股脉搏波速度（cfPWV）、年龄和血压之间的关系推导得出的公式计算出的估计颈股脉搏波速度（ePWV），是否与测量得到的cfPWV一样能很好地预测心血管疾病（CVD）。由于ePWV预测CVD的效果与cfPWV一样好，有些人可能会想ePWV是否可以被cfPWV取代，因为cfPWV测量耗时且需要昂贵的设备。本综述短文探讨了这个问题。
